I tried to purchase the related report 'Sprifermin Emerging Drug Insight and Market Forecast - 2032' but it seems to costs thousands!
I note two things already which give me hope.
I read in the link that their injection is intra-articular (into the joint), whereas ours is subcutaneous (under the skin) which I recall Mozz saying is the more comfortable option. (That's right, yes, Mozz?) I didn't see how many injections are required so that could be a deal breaker if results are similar.
Retreatment is required every 6-12 months, more frequently than ours, again in our favour.
I think there has been discussion about Sprifermin before on this platform. If anyone remembers where I can find it, I would appreciate your help.
I tried to purchase the related report 'Sprifermin Emerging Drug...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.3¢ | $111.8K | 474.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 154744 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 21128 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
0.005 ( 2.17 %) |
||||
| Open | High | Low | Volume | ||
| 23.5¢ | 24.0¢ | 23.5¢ | 63872 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| PAR (ASX) Chart |